Recurrent Ovarian Cancer

Avastin Plus Chemotherapy Improves Progression-Free Survival in Platinum-Resistant Recurrent Ovarian Cancer (04-9-2014)

The addition of Avastin® (bevacizumab) to standard chemotherapy significantly improved progression-free survival and objective response rate among women with platinum-resistant recurrent ovarian cancer, according to the results of a study published early... Continue Reading

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (02-20-2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

Dacogen Helps Recurrent Ovarian Cancer Respond to Vaccine (01-30-2014)

Treatment with Dacogen® (decitabine) prior to the administration of Adriamycin® (doxorubicin) and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, according to a study published in Cancer Immunology Research. Ovarian... Continue Reading

Cediranib Improves Survival in Recurrent Ovarian Cancer (10-21-2013)

Women with recurrent ovarian cancer experienced significantly improved survival when they received targeted agent cediranib with chemotherapy and as maintenance therapy after chemotherapy, according to the results of a study presented at the ESMO 2013... Continue Reading

Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (05-17-2013)

A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association for Cancer Research (AACR) Annual Meeting... Continue Reading

Ovarian Cancer Rates Declining in Breast Cancer Survivors (02-7-2013)

The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading

Diabetes Drug May Help Prevent or Treat Ovarian Cancer (12-3-2012)

Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading

Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (11-20-2012)

Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading

Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (09-28-2012)

Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading

Olaparib Improves Progression-Free Survival in Ovarian Cancer (08-10-2012)

Olaparib plus paclitaxel and carboplatin chemotherapy followed by olaparib maintenance therapy improved progression-free survival compared to chemotherapy alone in platinum-sensitive ovarian cancer, according to the results of a study presented at the... Continue Reading

« Previous PageNext Page »